logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Medico Remedies Ltd

Medico Remedies

Small Cap•213 Employees•IPO 2018
Current Price
₹41.37
-0.45 (-1.08%)Updated
NSE :MEDICO
BSE :540937
Sector :Pharmaceuticals
Today's Range
₹41.01
₹41.37
union icon
₹43.01
52 Week Range
52W Low₹37.18
52W High₹62.76
₹41.37
union icon
Downside11.27%
Upside51.70%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹396.91 Cr
Market Cap
Total market value of company
P/E Ratio
34.98
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
5.98
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹1.38
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
10.68%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
21.30%
ROCE
Return on Capital Employed. >15% is good
Net Margin
6.61%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
4.37%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
11.23%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
33.80%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
65.80%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.24
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹7.53
Book Value
Net asset value per share
Dividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
61.40%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

0 points

    Weaknesses

    0 points

      Opportunities

      0 points

        Threats

        0 points

          Segment-wise Financial Analysis

          Financial Results

          Balance Sheet

          Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format

          No Balance Sheet Data Available

          Standalone annual data is not available for this symbol.
          Try switching to Consolidated view.

          Shareholding Pattern

          Loading shareholding data...

          Company Insider Trading Activity

          No insider trading data available

          Corporate Action

          Company Announcements

          Technical Analysis & Indicators

          Standard pivot points - most widely used

          Pivot Points (CLASSIC)

          LevelPriceDistance% Change
          R4₹46.58+₹5.21+12.60%
          R3₹44.58+₹3.21+7.77%
          R2₹43.80+₹2.43+5.87%
          R1₹42.58+₹1.21+2.93%
          PIVOT₹41.800.431.03%
          CURRENT₹41.37--
          S1₹36.58-₹4.79-11.57%
          S2₹38.58-₹2.79-6.74%
          S3₹39.80-₹1.57-3.80%
          S4₹40.58-₹0.79-1.90%
          CPR Levels
          Support
          Resistance
          S4
          S3
          S2
          S1
          | CPR |
          BC: N/AP: N/ATC: N/A
          R1
          R2
          R3
          R4
          indicator
          LTP: N/A
          PDH: N/A
          PDL: N/A
          ● Market Sentiment

          is trading CPR, indicating

          ● CPR Width

          CPR is

          ● Opening Range

          Day's range: ~

          ● Price Position

          Trading Inside opening range

          Delivery Volume Analysis & Trading Activity

          Latest Volume
          1.08L
          (06 Mar 2026)
          -25.2% vs avg
          Delivery %
          56.8%
          (06 Mar 2026)
          +1.6% vs avg
          Avg Volume (20D)
          1.44L
          (06 Feb - 06 Mar)
          20-day average
          Avg Delivery %
          55.2%
          (06 Feb - 06 Mar)
          Trend ↓
          Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

          Peer Comparison & Industry Benchmarking

          Quick Compare

          Largest by Market Cap
          Sun Pharmaceutical Industries Ltd
          4.12L ₹ Cr
          Best Profit Growth
          Valiant Laboratories Ltd
          457.00 %
          Highest Dividend Yield
          Sun Pharmaceutical Industries Ltd
          0.91 %

          Peer Comparison

          Company Name
          ALBERTDAVD
          Albert David Ltd
          AMANTA
          HALEOSLABS
          Haleos Labs Limited
          MEDICAMEQ
          Medicamen Biotech Ltd
          SUNPHARMA
          Sun Pharmaceutical Industries Ltd
          VALIANTLAB
          Valiant Laboratories Ltd
          ZIMLAB
          Zim Laboratories Ltd

          About

          MEDICO

          Medico Remedies Ltd

          Medico Remedies Limited is an Indian pharmaceutical company engaged in the development, manufacturing, and sale of a diverse range of pharmaceutical and nutraceutical products. Their operations encompass a wide spectrum of therapeutic areas, catering to various healthcare needs within the Indian market and beyond.

          The company's product portfolio is extensive and includes a substantial number of therapeutic categories. This broad range covers antibiotics and anti-infectives, encompassing beta-lactams such as penicillins and cephalosporins, as well as antifungals. They also offer a significant selection of vitamins and supplements, addressing the growing demand for nutritional support. Further bolstering their offerings are cardiovascular products, pain management solutions (antipyretics, analgesics, and NSAIDs), gastrointestinal medications (antacids and anti-ulcer drugs), and treatments for mental health conditions (antidepressants, antipsychotics, and anti-epileptics). In addition, they produce antimalarials, various formulations like dry syrups, ointments, and creams, alongside anti-diabetics and other miscellaneous products.

          Beyond their core offerings, Medico Remedies also manufactures and sells diuretics, antiretrovirals, and steroidal preparations, demonstrating a commitment to providing a comprehensive suite of healthcare solutions. This wide-ranging inventory highlights their strategic positioning within the competitive pharmaceutical landscape. The company's commitment extends beyond the domestic market, as evidenced by their active involvement in exporting their products to international destinations, expanding their reach and market share.

          Established in 1994 and headquartered in Mumbai, India, Medico Remedies Limited has a history of providing a diverse array of pharmaceutical and nutraceutical products. Their comprehensive product portfolio, combined with their export activities, positions them as a significant player in the Indian and global pharmaceutical industry. The company's continued success hinges on its ability to innovate, adapt to evolving market demands, and maintain its commitment to providing high-quality healthcare solutions.

          COMPANY FACTS - MEDICO

          Registered Address

          Plot No-7,8,9, Dewan N Sons Udyog Nagar, Lokmanya Nagar, Palghar-West

          Thane

          MAHARASHTRA

          IN

          Tel: 918046047706

          Website:https://www.medicoremediesindia.com/

          Company Details

          Group: Pharmaceuticals, Biotechnology & Life Sciences

          Sector: Health Care

          Industry: Pharmaceuticals

          Exchange: NATIONAL STOCK EXCHANGE OF INDIA

          Employees: 213

          IPO Date: 08/02/2018

          MANAGEMENT - MEDICO

          Mr. Haresh Mehta

          Chairman of the Board, Legal Head and Chief Financial Officer

          Mr. Harshit Mehta

          Managing Director, Marketing & Export Head and Executive Director

          Mr. Rishit Mehta

          Production - Technical & Quality Control Head and Whole-time Director

          Mr. Maheshkumar Darji

          Additional Executive Director

          Mr. Gopal Jha

          Administration Manager

          Mrs. Priyal Mehta

          Marketing Manager

          Mr. Dushant Pandey

          Quality Control Manager

          Mrs. Rita Mehta

          Non-Executive Non-Independent Director

          Mr. Deepesh Shah

          Additional Independent Director

          Mr. Bharat Rathod

          Additional Non-Executive Independent Director

          Mr. Deepak Vekaria

          Additional Non-Executive Independent Director

          Mr. Kunal Vora

          Additional Non-Executive Independent Director

          Investor Questions Answered

          Medico Remedies Ltd (MEDICO) Stock FAQs

          Get answers to the most common questions about Medico Remedies Ltd stock price, fundamentals, financial metrics, and investment analysis

          The current share price of Medico Remedies Ltd (MEDICO) is ₹41.37. Today, the stock has declined by ₹0.45 (1.08%), trading in a range of ₹41.01 to ₹43.01. The stock opened at ₹41.85 with a trading volume of 1,07,669 shares.
          Medico Remedies Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹396.91 crores, P/E ratio of 34.98, ROE of 10.68%, and ROCE of 21.30%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
          The 52-week high price of Medico Remedies Ltd (MEDICO) is ₹62.76, while the 52-week low is ₹37.18. Currently trading at ₹41.37, the stock is 16.4% away from its 52-week low and 34.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
          Whether to buy Medico Remedies Ltd stock at ₹41.37 depends on multiple factors. The stock is currently trading with a P/E ratio of 34.98 and P/B ratio of N/A. Today's performance shows a loss of 1.08%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
          Medico Remedies Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹41.37, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
          Medico Remedies Ltd's key financial metrics include: P/E Ratio: 34.98, P/B Ratio: N/A, ROE: 10.68%, ROCE: 21.30%, Dividend Yield: 0.00%, EPS: ₹1.38, Book Value: ₹7.53, Debt-to-Equity: 0.24, and Current Ratio: N/A. The company's market cap stands at ₹396.91 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
          Medico Remedies Ltd stock opened at ₹41.85 and is currently trading at ₹41.37, showing a decline of ₹0.45 (1.08%). The intraday high is ₹43.01 and low is ₹41.01. The trading volume stands at 1,07,669 shares, indicating moderate market participation today.
          Medico Remedies Ltd has a Price-to-Earnings (P/E) ratio of 34.98, which means investors are willing to pay ₹34.98 for every ₹1 of earnings. With an EPS of ₹1.38, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
          Medico Remedies Ltd has a market capitalization of ₹396.91 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹41.37) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
          Medico Remedies Ltd has a book value of ₹7.53 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹41.37, which is 449.4% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
          Medico Remedies Ltd has a Return on Equity (ROE) of 10.68% and Return on Capital Employed (ROCE) of 21.30%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These are moderate returns, suggesting decent operational efficiency. Higher percentages generally indicate better financial performance.
          Medico Remedies Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
          Medico Remedies Ltd has a debt-to-equity ratio of 0.24, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
          Medico Remedies Ltd has an Earnings Per Share (EPS) of ₹1.38, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹41.37 and P/E ratio of 34.98, investors are paying 34.98 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
          Medico Remedies Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
          Medico Remedies Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
          To analyze Medico Remedies Ltd stock, consider: 1) Fundamental Analysis - Review P/E (34.98), ROE (10.68%), debt-to-equity (0.24), and growth rates. 2) Technical Analysis - Check 52-week range (₹37.18 - ₹62.76), moving averages, and chart patterns. 3) Valuation - Compare current price (₹41.37) with book value (₹7.53) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
          The face value (or par value) of Medico Remedies Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹41.37 is 1968x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
          Investing in Medico Remedies Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹37.18 - ₹62.76). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.24 indicates leverage. 4) Liquidity Risk - Based on trading volume of 1,07,669 shares. 5) Valuation Risk - P/E of 34.98 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
          Medico Remedies Ltd operates in the industry with key metrics: P/E ratio of 34.98, ROE of 10.68%, market cap of ₹396.91 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.24), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
          Target prices for Medico Remedies Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹41.37, with a 52-week range of ₹37.18 to ₹62.76. Based on fundamentals like P/E (34.98), ROE (10.68%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
          Consider selling Medico Remedies Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹41.37. 2) Fundamental Deterioration - Declining ROE (currently 10.68%), increasing debt (D/E: 0.24), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
          Tax implications for Medico Remedies Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.